Reese Pharmaceutical Company

Form 483

Cleveland, Ohio, United StatesFEI 1518939Issued January 11, 2012

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 1518939.

Observations5

Issue DateJanuary 11, 2012

StatusNo Warning Letter

Related Inspections8

Establishment Details

Firm: Reese Pharmaceutical Company
Location: Cleveland, Ohio, United States
FEI Number: 1518939
Product Type: Drugs
Issue Date: January 11, 2012
Country: United States

Inspection History, 2009 to 2025

NAI5

VAI2

OAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Reese Pharmaceutical Company FDA Form 483, Cleveland, Ohio, January 11, 2012